Skip to main content
Virbac logo

Virbac — Investor Relations & Filings

Ticker · FR000 ISIN · FR0000031577 LEI · 969500QQ1X5XHG649644 PA Manufacturing
Open in API
Filings indexed 975 across all filing types
Latest filing 2009-12-11 Declaration of Voting R…
Country FR France
Listing PA FR000

About Virbac

https://corporate.virbac.com/home.html

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.

Recent filings

Filing Released Lang Actions
VIRBAC : Declaration of the number of shares and voting rights as of November 30, 2009
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is explicitly titled 'DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS' and references Article 223-16 of the AMF General Regulations. It provides a table detailing the 'Total number of voting rights' as of a specific date (November 30, 2009). This content directly relates to the official declaration of voting rights and share capital structure, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a simple dividend notice.
2009-12-11 English
VIRBAC : Déclaration d'actions et de droits de vote au 30 novembre 2009
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document title is "DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration of Shares and Voting Rights). It explicitly references the total number of shares and the total number of voting rights as of a specific date (November 30, 2009), citing Article 223-16 of the AMF General Regulation. This content directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes or related voting rights disclosures.
2009-12-11 French
Communiqué
Regulatory Filings Classification · 90% confidence The document is a press release or communiqué from Virbac, a veterinary laboratory, discussing its long-term commitment to animal health, specifically focusing on the development and upcoming regulatory filing (AMM dossier) for a canine leishmaniasis vaccine. It details the disease, the development process since acquiring BVT in 2003, and the expected timeline for market launch (2011 or 2012) following the dossier submission in early 2010. This content is an announcement regarding a specific product development and regulatory milestone, not a comprehensive financial report (10-K, IR) or a general earnings release (ER). It is most closely related to general company news or a specific product/research update. Since there is no specific category for 'Product Development Update' or 'Regulatory Milestone Announcement' that isn't financial, and it is not a formal regulatory filing like a 10-K or a standard earnings release, it falls best under the general 'Regulatory Filings' (RNS) category as a significant corporate announcement, or potentially 'LTR' if viewed as a regulatory process update, but RNS is the broader fallback for non-financial, non-meeting related announcements. Given the focus on the upcoming 'dossier d'AMM' (marketing authorization application), it is a significant corporate/regulatory update. I will classify it as RNS as it is a general corporate communiqué about a major development.
2009-11-30 French
Virbac Press release
Regulatory Filings Classification · 95% confidence The document is a press release detailing a specific development in the company's product pipeline—the completion of efficacy and safety trials for a canine leishmaniosis vaccine and the plan to submit the registration dossier in early 2010. This is not a standard periodic financial report (like 10-K or IR), nor is it a management discussion (MDA) or earnings release (ER) focused on financial figures. It is an announcement concerning a specific corporate activity related to product development and regulatory submission timelines. Since it is a press release announcing a significant corporate event/update that doesn't fit the specific financial or governance codes (like CAP, LTR, or DIV), it falls best under the general 'Regulatory Filings' or 'Miscellaneous' category, which is RNS, as it is a general corporate announcement.
2009-11-30 English
VIRBAC : Declaration of the number of shares and voting rights as of October 31, 2009
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is explicitly titled 'DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS' and references Article 223-16 of the French Financial Market Authority (AMF) regulations. It provides a table detailing the total number of shares and the corresponding gross and net total voting rights as of a specific date (October 31, 2009). This content directly relates to the official declaration of voting rights and share capital structure, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a declaration of rights rather than results of a vote, DVA is the most specific category available for this type of regulatory filing concerning voting rights structure.
2009-11-06 English
VIRBAC : Déclaration d'actions et de droits de vote au 31 octobre 2009
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document title is "DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration of Shares and Voting Rights). It explicitly references the total number of voting rights and the total number of shares outstanding as of a specific date (October 31, 2009), citing a regulatory article (article 223-16 du Règlement Général de l'Autorité des Marchés Financiers). This content directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official announcements regarding the total number of voting rights.
2009-11-06 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.